|
[Older Americans Report
(entire issue);
28(45); 11/19/2004 in PDF format]
Laudable
as it might have been for the Drug Enforcement Administration (DEA) to provide
guidance on the proper use of narcotics, it is not the place of a law
enforcement agency to get involved in setting standards of care, according to a
lawyer in Portland, Oregon.
Eli Stutsman is president of Death with Dignity, which has been resisting
attempts by Attorney General John Ashcroft to preempt Oregon’s assisted-suicide
law (OAR, Nov. 12, p. 352). He also represents physicians and pharmacists in
other states who have been charged by the DEA with abusing their prescribing
privileges. But whether the issue is terminal illness or chronic pain, the
problem is that the DEA is arguing with
practitioners over what constitutes proper medical care, Stutsman said. “In
both instances, the DEA is looking over the shoulder of practitioners,” he told
OAR. “The standard of care is an issue for state law and not federal law.”
The DEA withdrew the guidelines shortly after posting them on its website Aug.
11 and this week published a
notice in the Federal Register giving a few of
its reasons. But Stutsman said the statement is
disingenuous because it does not mention that at least one physician
[Hurwitz] facing
DEA charges has attempted to use the guidelines in his own defense.
To convict practitioners, known as registrants, under the Controlled Substances
Act, the DEA must prove that a doctor or pharmacist knowingly or intentionally
distributed a controlled substance outside the course of professional practice.
In short, the agency must prove that such individuals “weren’t practicing
medicine,” Stutsman said. “It’s a specific-intent crime.” But that is hard to
prove. In fact, the DEA never alleged that diversion was taking place when it
challenged the assisted-suicide law, Stutsman said. “What they did instead is
they disagreed with the standard of care — they said, ‘You can’t do this.’”
Stutsman said he does not fault the doctors who have tried to get DEA to
provide them with guidance. But he warns that any such attempt is risky,
because the DEA itself is split on how to handle the issue of pain medications,
as its abrupt withdrawal of the guidelines made clear. “It backfired
horribly — the left hand didn’t know what the right hand was doing.”
Contact: Eli Stutsman, (503) 274-4048
-------------------------------------------------------
Siobhan
Reynolds
Family Member of a Chronic Pain Patient
President, Pain
Relief Network
[Older Americans Report
(entire issue);
28(45); 11/19/2004 in PDF format]
|